Loading provider…
Loading provider…
Medical Oncology Physician in Stanford, CA
NPI: 1205913589Primary Practice Location
STANFORD HEALTH CARE
300 Pasteur Dr, Stanford, CA
Primary Employer
Stanford Hospital
stanfordhealthcare.org
HQ Phone
Get MD Sandhya's Phone Numberphone_androidMobile
Get MD Sandhya's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1991 - 2027

American Board of Internal Medicine
Medical Oncology
Rochester Regional Health/Unity Hospital (Rochester)
Residency • Internal Medicine
1989 - 1991
Madras Medical College
Medical School
Until 1987
UCSF School of Medicine
medschool.ucsf.edu
Fellowship • Hematology and Medical Oncology
1991 - 1994
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 259 | 717 |
| 2 | 99204New patient office or other outpatient visit, 45-59 minutes | 80 | 80 |
| 3 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 44 | 183 |
| 4 | 99238Hospital discharge day management, 30 minutes or less | 31 | 33 |
| 5 | 99223Initial hospital inpatient care, typically 70 minutes per day | 26 | 26 |
Practice Makes Perfect: The Rest of the Story in Testicular Cancer as a Model Curable Neoplasm
Authors: Darren Feldman, Siamak Daneshmand, Costantine Albany
Journal: J Clin Oncol
Publication Date: 2017-08-30
Characterizing the outcomes of metastatic papillary renal cell carcinoma.
Lead Sponsor: Stanford University
Collaborators: National Institutes of Health (NIH), National Cancer Institute (NCI)
Intervention / Treatment: DIAGNOSTIC_TEST: Doppler ultrasound, DIAGNOSTIC_TEST: Long Ensemble Angular-coherence Doppler [LEAD] ultrasound, DIAGNOSTIC_TEST: Contrast-enhanced ultrasound (CEUS)
Lead Sponsor: Endocyte
Intervention / Treatment: DRUG: 177Lu-PSMA-617, OTHER: Best supportive/best standard of care
Lead Sponsor: Stanford University
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, PROCEDURE: Positron Emission Tomography, DRUG: Fludeoxyglucose F-18, PROCEDURE: Contrast-enhanced Magnetic Resonance Imaging, DRUG: Fluorine F 18 Sodium Fluoride